Work

Supplemental Figure 6 from Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor

Year: 2024

Type: supplementary-materials

Abstract: Supplemental Figure 6. Cell survival of GIST T1 cells treated with imatinib or avapritinib for 72h in complete media. Each data point represents an average of 10 wells.

DOI: 10.1158/1078-0432.27030505.v1

Authors: Ferdinand Rossi, Mengyuan Liu, Andrew Tieniber, Mark S. Etherington, Andrew Hanna, Gerardo A. Vitiello, Nesteene J. Param, Kevin Do, Laura Wang, Cristina R. Antonescu, Shan Zeng, Jennifer Q. Zhang, Ronald P. DeMatteo

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402800912

Cites:

Cited by:

Related to: 10